Emerging China is the third in a series of four reports by the Economist Intelligence Unit. It is part of the Reinventing biopharma: Strategies for an evolving marketplace programme, sponsored by Quintiles. The findings and views expressed in this report do not necessarily reflect the views of the sponsor.

The author was Dr Paul Kielstra. The editor was Diallo Hall, and Mike Kenny was responsible for layout.